BILLERICA, Mass. & SAN DIEGO--(BUSINESS WIRE)--RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced the availability of its ThunderBolts™ Cancer Panel, a comprehensive next-generation DNA sequencing (NGS) solution that enables researchers to profile a wide range of tumor samples in fewer than two days for as low as $100 per sample. During this week’s American Association for Cancer Research (AACR) Annual Meeting, several prominent cancer researchers and collaborators in RainDance’s First Access Program (FAP) will present their latest findings demonstrating the product’s high sensitivity, low starting sample requirements and simple workflow in breast, colorectal, esophageal, and pancreatic cancer studies. These leading researchers will share their data and experience using the ThunderBolts Cancer Panel for profiling tumor samples and the RainDrop Digital™ PCR System for follow-up mutation validation.
Help employers find you! Check out all the jobs and post your resume.
